HRT Financial’s Denali Therapeutics DNLI Stock Holding History

HRT Financial’s Portfolio DNLI Stock Details DNLI Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.29M	Buy
2024 Q4	–	Sell
2024 Q3	$493K	Buy
2024 Q1	–	Sell
2023 Q4	$950K	Buy
2023 Q3	$251K	Buy
2022 Q4	–	Sell
2022 Q3	$2.38M	Buy
2022 Q2	$694K	Buy